Renascience Inc. (TYO:4889)

Japan flag Japan · Delayed Price · Currency is JPY
1,701.00
+34.00 (2.04%)
Jun 24, 2026, 11:30 AM JST
Market Cap22.97B +10.5%
Revenue (ttm)68.00M -48.5%
Net Income-301.00M
EPS-23.37
Shares Out 13.78M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume106,000
Open1,666.00
Previous Close1,667.00
Day's Range1,643.00 - 1,704.00
52-Week Range1,108.00 - 3,310.00
Beta1.72
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About Renascience

Renascience Inc. engages in the development and commercialization of pharmaceuticals and medical devices in Japan. The company is developing RS5614, a PAI-1 inhibitor product candidate for use in the treatment of chronic myeloid leukemia, malignant melanoma, non-small cell lung cancer, cutaneous angio-sarcoma, coronavirus lung injury, and interstitial lung disease associated with systemic scleroderma; RS5441, PAI-1 inhibitor for the treatment of alopecia disease that is in Phase I clinical trials; and RS8001, a water-soluble vitamin for use in ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 3
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4889
Full Company Profile

Financial Performance

Financial Statements